Today, infants of mothers with active HBV infection receive hepatitis B immunoglobulin at birth and the hepatitis B vaccine series substantially reducing the risk of neonatal transmission. 8-1z Failures of immunoprophylaxis programs (as low as 1%) are usually due to noncompliance with vaccination protocols; however, a few failures (estimated to be less than 10%) may be due to antepartum transmission. 1, 2, [4] [5] [6] [7] 11 Although the mechanism of antepartum fetal hepatitis B transmission is not well understood, there is concern that invasive procedures such as amniocentesis may increase the risk. Amniocentesis can result in disruption of the placenta with fetal and maternal blood exchange. Additionally, maternal blood from the uterus 
